National Immunotherapy Cancer Research Foundation Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2010 | 231,121 | 173,707 | 57,414 | 32.3 | 0% |
| 2011 | 218,398 | 10,148 | 208,250 | 787.1 | 0% |
| 2012 | 270,078 | 14,459 | 255,619 | 764.5 | 0% |
| 2013 | 294,057 | 126,708 | 167,349 | 103.1 | 0% |
| 2014 | 294,368 | 52,174 | 242,194 | 306.1 | 0% |
| 2015 | 286,957 | 575,682 | −288,725 | 21.7 | 0% |
| 2016 | 233,882 | 227,692 | 6,190 | 55.2 | 0% |
| 2017 | 299,954 | 252,816 | 47,138 | 52.0 | 0% |
| 2018 | 328,141 | 29,367 | 298,774 | 569.7 | 0% |
| 2019 | 330,414 | 32,577 | 297,837 | 623.3 | 0% |
| 2020 | 13,978 | 1,023,158 | −1,009,180 | 8.0 | 0% |
| 2021 | 6,004 | 77,669 | −71,665 | 94.4 | 0% |
| 2022 | 4,423 | 136,357 | −131,934 | 42.2 | 0% |
| 2023 | 151,460 | 98,040 | 53,420 | 72.2 | 0% |
In its most recent public year (2023), this organization brought in $53,420 more than it spent. Its reserves stood at about 72.2 months of spending, up from 32.3 in 2010. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works